Article
Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions.
BMC medical genomics - 8 Feb 2022
Gao Beibei, Tan Tingfei, Cao Xi, Pan Menglu, Yang Chunlan, Wang Jianxiong, Shuai Zongwen, Xia Quan
Abstract excerpt
BACKGROUND: Hydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This study aimed to investigate the relationship of cytochrome P450 (CYP450) gene polymorphisms with blood concentrations of HCQ and its metabolites and adverse drug reactions (ADRs) in patients with SLE and RA. METHODS: A cohort of 146 patients with SLE and RA treated with HCQ was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
